Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Equity/Stock(s)/Options (Personal) - Shockwave Medical
- Consultant Fee/Honoraria/Speaker's Bureau (Both) - Shockwave Medical; Abbott Vascular; Boston Scientific Corporation; Medtronic
- Grant Support/Research Contract (Institutional) - Shockwave Medical; Abbott Vascular; Boston Scientific Corporation
- Grant Support/Research Contract (Both) - Abiomed
- Consultant Fee/Honoraria/Speaker's Bureau (Institutional) - Abiomed